PEBP1 and neoplasm: An important pathway involving YY1 is the NF-κB/YY1/ RKIP regulatory axis, which has been shown to significantly contribute to tumor cell resistance against both chemotherapy and immunotherapy-induced cytotoxicity [47,48,49].